Cite
On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF.
MLA
Kittipibul, Veraprapas, et al. “On‐treatment Analysis of Torsemide versus Furosemide for Patients Hospitalized for Heart Failure: A Post‐hoc Analysis of TRANSFORM‐HF.” European Journal of Heart Failure, May 2024, p. 1. EBSCOhost, https://doi.org/10.1002/ejhf.3293.
APA
Kittipibul, V., Mentz, R. J., Clare, R. M., Wojdyla, D. M., Anstrom, K. J., Eisenstein, E. L., Ambrosy, A. P., Goyal, P., Skopicki, H. A., Ketema, F., Kim, D., Desvigne, N. P., Pitt, B., Velazquez, E. J., & Greene, S. J. (2024). On‐treatment analysis of torsemide versus furosemide for patients hospitalized for heart failure: A post‐hoc analysis of TRANSFORM‐HF. European Journal of Heart Failure, 1. https://doi.org/10.1002/ejhf.3293
Chicago
Kittipibul, Veraprapas, Robert J. Mentz, Robert M. Clare, Daniel M. Wojdyla, Kevin J. Anstrom, Eric L. Eisenstein, Andrew P. Ambrosy, et al. 2024. “On‐treatment Analysis of Torsemide versus Furosemide for Patients Hospitalized for Heart Failure: A Post‐hoc Analysis of TRANSFORM‐HF.” European Journal of Heart Failure, May, 1. doi:10.1002/ejhf.3293.